CKD Bio Obtains European CoS Accreditation for Antibiotic Raw Material

Published: 2005-03-14 06:59:00

Updated: 2005-03-14 06:59:00

CKD Bio Corp., an affiliate of Chong Kun Dang Group specialized in the manufacture of pharmaceutical raw materials, announced that the company has successfully obtained a CoS (Certificate of Suitability) accreditation for its clavulanate potassium.

Clavulanate potassium, an antibiotic raw material, was developed by CKD Bio in Year 2002, and is used in combination with Amoxycillin or Ticacil...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.